Proxyphylline

Porphyria.

Peptic ulceration, hyperthyroidism, hypertension, cardiac arrhythmias or other CV disease, or epilepsy, heart failure, hepatic dysfunction or chronic alcoholism, acute febrile illness. Neonates and elderly.

Nausea, vomiting, abdominal pain, diarrhoea, gastro-oesophageal reflux and other GI disturbances, insomnia, headache, anxiety, restlessness, dizziness, tremor and palpitations.

Concurrent use with other xanthines may cause additive toxic effects. Clearance may be reduced by allopurinol, some antiarrhythmics, cimetidine, disulfiram, fluvoxamine, interferon alfa, macrolide antibacterials and quinolones, oral contraceptives, tiabendazole and viloxazine. Phenytoin and some other antiepileptics, ritonavir, rifampicin and sulfinpyrazone may increase theophylline clearance. Increased risk of seizures when used concurrently with imipenem. May potentiate hypokalaemia caused by hypoxia or when used with β-adrenoceptor stimulants, corticosteroids and diuretics. May increase the clearance of lithium.

Description:
Mechanism of Action: Proxyphylline is a derivative of theophylline which is used as a bronchodilator and for its CV properties.

Thuốc trị hen & bệnh phổi tắc nghẽn mạn tính